CANCERLINQ
The "CANCERLINQ" trademark, serial number 85524713 , was filed on 25th of January 2012 with a mark drawing code of 4000 and its transaction date is 85524713. The attorney assigned is Emilia F, Cannella, attorney docket number ASCO-T-065. Since 11th of June 2014, the document can be found in the M40 law office in the publication and issue section. The date when we last checked the status of this trademark was 06/11/2014.
Prior registrations: 85978639 (Continuity Child)
The corresponded responsible for this trademark is EMILIA F, CANNELLA, located at ROPES & GRAY LLP, PRUDENTIAL TOWER 800 BOYLSTON ST, BOSTON, MA 02199.The state or country where the trademark was organized is VA by American Society Of Clinical Oncology, Inc.. The legal entity type behing it is a Corporation, located at 2318 Mill Road, Suite 800, Alexandria, VA zip 22314.
| GOODS AND/OR SERVICES | |
| International Class - 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. | |
|---|---|
| U.S. Class | 101 - Advertising and Business |
| Class Status | 6 - Active |
| Status Date | 11/21/2012 |
| Primary Code | 042 |
| International Class - 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. | |
| U.S. Class | 101 - Advertising and Business |
| Class Status | 6 - Active |
| Status Date | 01/28/2012 |
| Primary Code | 044 |
| Goods codes | |
| GS0421 | Providing medical and scientific research information in the field of neoplastic diseases to medical and scientific researchers; providing medical and scientific research information in the field of clinical trials for neoplastic diseases; application service provider featuring software for use in providing on-line medical databases; providing quality assurance services in the field of healthcare, namely, collecting, comparing, and analyzing of patient-level medical and clinical healthcare quality data and preparing reports in connection therewith for the purpose of analyzing the quality of cancer care and treatment |
| GS0441 | Providing information in the field of neoplastic disease prevention, screening, diagnosis and treatment for use by physicians and other health care providers in the field of neoplastic diseases; providing patient information in the field of neoplastic diseases |
| PM0000 | CANCER LINK |
| PROSECUTION HISTORY | ||||
| Date | Description | Type | Code | |
|---|---|---|---|---|
| 06/11/2014 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | S | RCSC - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | |
| 12/09/2013 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | S | RCSC - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | |
| 06/03/2013 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | S | RCSC - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | |
| 02/19/2013 | ATTORNEY REVIEW COMPLETED | O - Outgoing Correspondence | ATRV - ATTORNEY REVIEW COMPLETED | |
| 02/19/2013 | DIVISIONAL PROCESSING COMPLETE | D - Assigned to Examiner | DPCC - DIVISIONAL PROCESSING COMPLETE | |
| 01/29/2013 | DIVISIONAL REQUEST RECEIVED | I - Incoming Correspondence | DRRR - DIVISIONAL REQUEST RECEIVED | |
| 02/13/2013 | CASE ASSIGNED TO INTENT TO USE PARALEGAL | A - Allowance for Publication | AITU | |
| 01/29/2013 | TEAS REQUEST TO DIVIDE RECEIVED | I - Incoming Correspondence | ERTD | |
| 11/29/2012 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | O - Outgoing Correspondence | GNS3 | |
| 11/29/2012 | LETTER OF SUSPENSION E-MAILED | S | GNSL - LETTER OF SUSPENSION E-MAILED | |
| 11/29/2012 | SUSPENSION LETTER WRITTEN | R - Renewal | CNSL - SUSPENSION LETTER WRITTEN | |
| 11/21/2012 | TEAS/EMAIL CORRESPONDENCE ENTERED | I - Incoming Correspondence | TEME - TEAS/EMAIL CORRESPONDENCE ENTERED | |
| 11/21/2012 | CORRESPONDENCE RECEIVED IN LAW OFFICE | I - Incoming Correspondence | CRFA - CORRESPONDENCE RECEIVED IN LAW OFFICE | |
| 11/16/2012 | ASSIGNED TO LIE | A - Allowance for Publication | ALIE - ASSIGNED TO LIE | |
| 11/08/2012 | TEAS RESPONSE TO OFFICE ACTION RECEIVED | I - Incoming Correspondence | TROA - TEAS RESPONSE TO OFFICE ACTION RECEIVED | |
| 05/08/2012 | NOTIFICATION OF NON-FINAL ACTION E-MAILED | O - Outgoing Correspondence | GNRN | |
| 05/08/2012 | NON-FINAL ACTION E-MAILED | F - First Action | GNRT - NON-FINAL ACTION E-MAILED | |
| 05/08/2012 | NON-FINAL ACTION WRITTEN | R - Renewal | CNRT - NON-FINAL ACTION WRITTEN | |
| 05/03/2012 | ASSIGNED TO EXAMINER | D - Assigned to Examiner | DOCK - ASSIGNED TO EXAMINER | |
| 01/31/2012 | NOTICE OF PSEUDO MARK MAILED | O - Outgoing Correspondence | MPMK | |
| 01/28/2012 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | I - Incoming Correspondence | NWOS | |
| 01/28/2012 | NEW APPLICATION ENTERED IN TRAM | I - Incoming Correspondence | NWAP - NEW APPLICATION ENTERED IN TRAM | |
The "CANCERLINQ" trademark, serial number 85978639 , was filed on 25th of January 2012 with a mark drawing code of 4000 and its transaction date is 85978639. The attorney assigned is Emilia F, Cannella, attorney docket number ASCO-T-065. Since 29th of May 2014, the document can be found in the M40 law office in the publication and issue section. The employee responsible is MONINGHOFF, KIM TERESA and the date it was published for opposition on 03/26/2013. The status of this trademark was checked last on 05/28/2014.
Information gathered on 12/31/2009. No claim is made regarding the current trademark status. This page is not to be used as legal documentation. Always consult a licensed attorney.
This web site is not associated with, endorsed by, or sponsored by and has no official or unofficial affiliation with the trademark's owners.